ID   LCL-26
AC   CVCL_C3HP
DR   Wikidata; Q114311874
RX   PubMed=11175312;
RX   PubMed=15755994;
RX   PubMed=16045799;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ70 ! RCC-26
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=11175312; DOI=10.1038/sj.gt.3301349;
RA   Schendel D.J., Frankenberger B., Jantzer P., Cayeux S., Noessner E.,
RA   Willimsky G., Maget B., Pohla H., Blankenstein T.;
RT   "Expression of B7.1 (CD80) in a renal cell carcinoma line allows
RT   expansion of tumor-associated cytotoxic T lymphocytes in the presence
RT   of an alloresponse.";
RL   Gene Ther. 7:2007-2014(2000).
//
RX   PubMed=15755994; DOI=10.1158/1078-0432.CCR-04-1883;
RA   Frankenberger B., Pohla H., Noessner E., Willimsky G., Papier B.,
RA   Pezzutto A., Kopp J., Oberneder R., Blankenstein T., Schendel D.J.;
RT   "Influence of CD80, interleukin-2, and interleukin-7 expression in
RT   human renal cell carcinoma on the expansion, function, and survival of
RT   tumor-specific CTLs.";
RL   Clin. Cancer Res. 11:1733-1742(2005).
//
RX   PubMed=16045799; DOI=10.1186/1479-5876-3-29; PMCID=PMC1188079;
RA   Geiger C., Regn S., Weinzierl A., Noessner E., Schendel D.J.;
RT   "A generic RNA-pulsed dendritic cell vaccine strategy for renal cell
RT   carcinoma.";
RL   J. Transl. Med. 3:29.1-29.15(2005).
//